商务合作
动脉网APP
可切换为仅中文
Round includes co-investment from the New Jersey Innovation Evergreen Fund
本轮融资包括来自新泽西创新常青基金的共同投资
Nokia Bell Labs spin-out will move its imaging engine into partner medical device applications
诺基亚贝尔实验室的衍生公司将把其成像引擎应用于合作伙伴的医疗设备中
MURRAY HILL, N.J.
新泽西州默里山
,
,
Nov. 17, 2026
2026年11月17日
/PRNewswire/ -- AstraNu, developer of the first chip-scale optical coherence tomography (OCT) imaging engine for the medical device industry, today announced it has closed $3.5 million in seed funding. The round was led by Celesta Capital, with co-investment from the New Jersey Innovation Evergreen Fund (NJIEF), a program of the New Jersey Economic Development Authority (NJEDA)..
/美通社/ -- 医疗设备行业首款芯片级光学相干断层扫描(OCT)成像引擎开发商AstraNu今日宣布完成350万美元的种子轮融资。本轮融资由Celesta Capital领投,新泽西州经济发展局(NJEDA)旗下的新泽西创新常青基金(NJIEF)跟投。
AstraNu spun out of Nokia Bell Labs in May 2025 with backing from Celesta, the first venture in the two companies' collaboration to commercialize Bell Labs technologies. The company has since achieved swept-source OCT performance at chip scale and is ready to demonstrate and validate it with application partners..
AstraNu 于 2025 年 5 月从诺基亚贝尔实验室分拆成立,并获得 Celesta 的支持。这是两家公司合作将贝尔实验室技术商业化的首个风险投资项目。此后,该公司已在芯片尺度上实现了扫频源光学相干断层扫描(OCT)的性能,并准备与应用合作伙伴一起进行演示和验证。
AstraNu will use the funding to build its photonics development team, validate the performance of its engine, and prepare for volume manufacturing.
AstraNu 将利用这笔资金组建其光子学研发团队,验证其发动机的性能,并为大规模量产做好准备。
'This funding enables us to drive our strategy forward by building out our photonics development team and manufacturing readiness ahead of customer volume,' said Kevin Blalock, President and General Manager of AstraNu. 'Celesta's backing, together with the NJIEF's support, gives us the runway to get our engine into partner testbeds and validate the performance we have achieved.'.
AstraNu 总裁兼总经理 Kevin Blalock 表示:“这笔资金使我们能够通过扩充光子学研发团队并提前为应对客户大规模需求做好制造准备,从而推动我们的战略向前发展。Celesta 的支持以及新泽西创新经济基金(NJIEF)的资助,为我们提供了充足的资源,使我们的引擎能够进入合作伙伴的测试平台,并验证我们所取得的性能成果。”
Swept-source OCT (SS-OCT) can deliver faster, deeper imaging than legacy spectral-domain OCT (SD-OCT), but to date its cost and size have limited the reach of its applications. Developed at Nokia Bell Labs, AstraNu's engine delivers SS-OCT imaging performance at SD-OCT price points – delivering a module more than 10x smaller and significantly lower in cost than conventional swept-source systems.
扫频源光学相干断层扫描(SS-OCT)能够提供比传统谱域光学相干断层扫描(SD-OCT)更快、更深的成像,但迄今为止,其成本和体积限制了其应用范围。由诺基亚贝尔实验室开发的AstraNu引擎,以SD-OCT的价格水平实现了SS-OCT的成像性能——其模块体积比传统扫频源系统小10倍以上,成本也显著降低。
The company supplies this imaging engine to established medical device, imaging, and optics companies looking to integrate high-performance OCT into their own products. Ophthalmology, the largest current market for the technology, is its initial commercial focus, and the company is also working with developers of applications in ENT, urology, and oncology, among others..
该公司向寻求将高性能光学相干断层扫描(OCT)技术集成到自身产品中的成熟医疗设备、成像和光学公司提供此成像引擎。眼科是目前该技术最大的市场,也是其初始的商业重点;此外,该公司还在与耳鼻喉科、泌尿科和肿瘤科等应用领域的开发者开展合作。
'AstraNu is an outstanding example of where we invest: foundational technology from one of the world's leading research labs, with the potential to change what is possible in a large and established market,' said Matthew Marsh, Managing Partner and CFO of Celesta Capital. 'By delivering a new cost and performance package, AstraNu is opening this imaging technology to entirely new applications and markets.
“阿斯特拉努(AstraNu)是我们投资方向的杰出典范:它源自全球顶尖研究机构之一的基础技术,有望在庞大且成熟的市场中突破现有局限,拓展可能性的边界。”Celesta Capital 的管理合伙人兼首席财务官马修·马什(Matthew Marsh)表示,“通过提供全新的成本与性能组合,阿斯特拉努正将这一成像技术推向截然不同的全新应用与市场。”
Scaling a technology like this from the lab into volume production requires disciplined operations and commercial partners – supporting founders in this work is what we do. Celesta is delighted to lead this round alongside NJEDA, and to continue our partnership with Nokia to build globally competitive companies around market-shifting technologies.'.
将此类技术从实验室阶段推进至大规模量产,需要严谨的运营体系与商业合作伙伴的支持——而协助创始人完成这一工作正是我们的使命。Celesta 很高兴能与新泽西州经济发展局(NJEDA)共同领投本轮融资,并继续与诺基亚保持合作,围绕具有市场变革意义的技术打造具备全球竞争力的企业。
Medical device, imaging and optics companies interested in evaluating the engine can contact AstraNu at
有意评估该引擎的医疗设备、成像及光学公司可联系 AstraNu,联系方式如下:
[email protected]
[email protected]
.
。
About AstraNu, Inc.
关于 AstraNu 公司
AstraNu develops a chip-scale optical coherence tomography imaging engine that gives medical device manufacturers swept-source performance at a fraction of the size and cost of conventional systems – enabling high-performance imaging in new products and new clinical applications.. The company spun out of Nokia Bell Labs in 2025 and is headquartered in Murray Hill, New Jersey.
AstraNu 开发了一种芯片级光学相干断层扫描(OCT)成像引擎,使医疗设备制造商能够以远低于传统系统的尺寸和成本实现扫频源性能,从而在新产品和新临床应用中实现高性能成像。该公司于 2025 年从诺基亚贝尔实验室分拆成立,总部位于新泽西州默里山。
For more information, visit astranu.com..
更多信息,请访问 astranu.com。
About Celesta Capital
关于 Celesta Capital
Celesta Capital is a venture capital firm built by global deep tech operators. Since 2013, we've backed the foundational technologies that unlock every major technology wave: semiconductors and intelligent hardware, bio-convergence, and industry transformers. Founded by Silicon Valley veterans who've built, scaled, and exited major global technology companies, today we bring that operating experience to support deep tech founders from breakthrough to global scale.
Celesta Capital 是一家由全球深度科技运营专家打造的 Venture Capital(风险投资)公司。自2013年以来,我们一直支持那些开启每一轮重大技术浪潮的基础性技术:半导体与智能硬件、生物融合以及产业变革者。公司由曾在硅谷创建、规模化发展并成功退出多家全球知名科技公司的资深人士创立,如今我们将这些运营经验带给深度科技创业者,助力他们从技术突破走向全球规模化发展。
For more information, visit .
更多信息,请访问。
www.celesta.vc
www.celesta.vc
.
。
Media Contact:
媒体联系人:
Kevin Blalock
凯文·布莱洛克
[email protected]
[email protected]
SOURCE AstraNu
来源 AstraNu